Search research articles
Contact Us
Filters
Showing results (91-100 of 262) with videos related to
Page
of 27
Sort By:
Pharmacoepidemiology and Drug Safety
|
October 19, 2007
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients
Gary D Friedman, E Dawn Flick, Natalia Udaltsova, et al.
Annals of Surgical Oncology
|
January 13, 2026
Multigene Germline Testing in Patients with DCIS vs Invasive Breast Cancer in a Large, Integrated Health Care System
Jessica M Dzubnar, Laurel A Habel, Sheng-Fang Jiang, et al.
Cancer
|
December 12, 2025
Is age just a number? Oncotype DX testing and chemotherapy use in the post-TAILORx era
Ashely Aller, Shiyun Zhu, Liisa Lyon, et al.
Journal of Internal Medicine
|
May 9, 2017
Hydrochlorothiazide use is strongly associated with risk of lip cancer
A Pottegård, J Hallas, M Olesen, et al.
Sexually Transmitted Diseases
|
February 9, 2018
Preparing for the Chlamydia and Gonorrhea Self-Test
Thomas A Peterman, Kristen Kreisel, Melissa A Habel, et al.
Neuroscience Letters
|
July 19, 2008
TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin
T Gaiser, M R Becker, A Habel, et al.
Sexually Transmitted Diseases
|
May 8, 2023
A Description of Telehealth Use Among Sexually Transmitted Infection Providers in the United States, 2021
William S Pearson, Philip A Chan, Melissa A Habel, et al.
Journal of the National Cancer Institute
|
October 7, 2004
Mammographic density and breast cancer after ductal carcinoma in situ
Laurel A Habel, James J Dignam, Stephanie R Land, et al.
Annals of Surgery
|
January 1, 1997
Risk of contralateral breast cancer among women with carcinoma in situ of the breast
L A Habel, R E Moe, J R Daling, et al.
Breast Cancer Research and Treatment
|
December 2, 2005
Use of raloxifene among women with a history of breast cancer
Laurel A Habel, Alice Pressman, Bruce Ettinger, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 262) with videos related to
Sort By:
Page
of 27
Pharmacoepidemiology and Drug Safety
|
October 19, 2007
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients
Gary D Friedman, E Dawn Flick, Natalia Udaltsova, et al.
Annals of Surgical Oncology
|
January 13, 2026
Multigene Germline Testing in Patients with DCIS vs Invasive Breast Cancer in a Large, Integrated Health Care System
Jessica M Dzubnar, Laurel A Habel, Sheng-Fang Jiang, et al.
Cancer
|
December 12, 2025
Is age just a number? Oncotype DX testing and chemotherapy use in the post-TAILORx era
Ashely Aller, Shiyun Zhu, Liisa Lyon, et al.
Journal of Internal Medicine
|
May 9, 2017
Hydrochlorothiazide use is strongly associated with risk of lip cancer
A Pottegård, J Hallas, M Olesen, et al.
Sexually Transmitted Diseases
|
February 9, 2018
Preparing for the Chlamydia and Gonorrhea Self-Test
Thomas A Peterman, Kristen Kreisel, Melissa A Habel, et al.
Neuroscience Letters
|
July 19, 2008
TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin
T Gaiser, M R Becker, A Habel, et al.
Sexually Transmitted Diseases
|
May 8, 2023
A Description of Telehealth Use Among Sexually Transmitted Infection Providers in the United States, 2021
William S Pearson, Philip A Chan, Melissa A Habel, et al.
Journal of the National Cancer Institute
|
October 7, 2004
Mammographic density and breast cancer after ductal carcinoma in situ
Laurel A Habel, James J Dignam, Stephanie R Land, et al.
Annals of Surgery
|
January 1, 1997
Risk of contralateral breast cancer among women with carcinoma in situ of the breast
L A Habel, R E Moe, J R Daling, et al.
Breast Cancer Research and Treatment
|
December 2, 2005
Use of raloxifene among women with a history of breast cancer
Laurel A Habel, Alice Pressman, Bruce Ettinger, et al.
Page
of 27